CD56brightCD16+ NK cells expressing KIR2DS4 were also significantly increased in controls and moderate CFS/ME patients after 6 months (p = 0.038 and 0.023) (Fig. 4d). The gene discussed is KIR2DS4; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.